⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9939172 | 0.78 | — | — | |
| SCHEMBL11911324 | 0.75 | — | — | |
| SCHEMBL11912467 | 0.75 | — | — | |
| SCHEMBL5704819 | 0.75 | — | — | |
| SCHEMBL15468771 | 0.75 | ALDH1A1 (0.33) | — | |
| SCHEMBL13222568 | 0.75 | — | — | |
| SCHEMBL14619109 | 0.75 | — | — | |
| Fluoromethane SCHEMBL1057461 | 0.73 | — | — | |
| SCHEMBL20812084 | 0.72 | TSHR (0.31) | — | |
| SCHEMBL14721642 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1015039-B1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2008-08-27 | — | — | EP | claimed |
| US-7105151-B2 | Oxygen delivery agents and uses for the same | IMARX THERAPEUTICS, INC. (US) | 2006-09-12 | — | — | US | claimed |
| US-20030120204-A1 | Oxygen delivery agents and uses for the same | CEREVAST THERAPEUTICS, INC. | 2003-06-26 | — | — | US | claimed |
| EP-1015039-A4 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2002-09-11 | — | — | EP | claimed |
| EP-1015039-A1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-07-05 | — | — | EP | claimed |
| WO-1998057670-A1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-12-23 | — | — | WO | claimed |
| EP-2766001-B1 | BUFFERED OXYGEN THERAPEUTIC | NUVOX PHARMA LLC (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023242598-A1 | BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION | AMPHISTA THERAPEUTICS LIMITED (GB) | 2023-12-21 | — | — | WO | disclosed |
| US-11827612-B2 | Hydroxamic acid derivative, method for producing same and use thereof | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11827612-B2 | Hydroxamic acid derivative, method for producing same and use thereof | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-11-28 | — | — | US | disclosed |
| US-20230265055-A1 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | OXFORD FINANCE LLC | 2023-08-24 | — | — | US | disclosed |
| US-20230227484-A1 | PYRIMIDINE COMPOUND AS AXL INHIBITOR | NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. (CN) | 2023-07-20 | — | — | US | disclosed |
| US-20230227484-A1 | PYRIMIDINE COMPOUND AS AXL INHIBITOR | NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. (CN) | 2023-07-20 | — | — | US | disclosed |
| US-20070043023-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2007-02-22 | — | — | US | disclosed |
| US-7105151-B2 | Oxygen delivery agents and uses for the same | IMARX THERAPEUTICS, INC. (US) | 2006-09-12 | — | — | US | disclosed |
| US-20030120204-A1 | Oxygen delivery agents and uses for the same | CEREVAST THERAPEUTICS, INC. | 2003-06-26 | — | — | US | disclosed |
| US-6537246-B1 | Blood substitutes comprising a fluorinated gas and a stabilizing aqueous solution containing lipids; the perfluorocarbon compounds, perfluorooctylbromide and perfluorohexane, are preferred | IMARX THERAPEUTICS, INC. | 2003-03-25 | — | — | US | disclosed |
| EP-1015039-A4 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2002-09-11 | — | — | EP | disclosed |
| EP-1015039-A1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-1998057670-A1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-12-23 | — | — | WO | disclosed |